New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
09:06 EDTACADACADIA price target raised to $42 from $28 at Piper Jaffray
Piper Jaffray raised its price target for ACADIA Pharmaceuticals to $42 citing the company's pipeline progress following its Q4 results. The firm keeps an Overweight rating on the stock.
News For ACAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ACAD

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use